Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Ban

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
Annals of Surgery|September 17, 2020
Curative Surgery and Ki-67 Value Rather Than Tumor Differentiation Predict the Survival of Patients With High-grade Neuroendocrine NeoplasmsDaisuke Asano, Atsushi Kudo, Keiichi Akahoshi, et al.
Anticancer Research|August 2, 2019
High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular CarcinomaShun-Ichi Ariizumi, Daisuke Ban, Yuta Abe, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2016
Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasmEriko Katsuta, Atsushi Kudo, Takumi Akashi, et al.
Journal of Gastroenterology|March 14, 2019
A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasmsBo Liu, Atsushi Kudo, Yuko Kinowaki, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2021
A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasmsTomotaka Kato, Atsushi Kudo, Yuko Kinowaki, et al.
Gastroenterology|April 19, 2012
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agentsRama Adikrisna, Shinji Tanaka, Shunsuke Muramatsu, et al.
Annals of Surgical Oncology|December 28, 2013
EpCAM-targeted therapy for human hepatocellular carcinomaKousuke Ogawa, Shinji Tanaka, Satoshi Matsumura, et al.
Cancer Science|September 12, 2021
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancersYoshiki Murase, Hiroaki Ono, Kosuke Ogawa, et al.
Surgical Case Reports|October 8, 2025
Late-Onset Para-Aortic Lymph Node Recurrence 11 Years after Resection of Pancreatic Cancer: Histological Reassessment Revealed Neuroendocrine Differentiation Amenable to Surgical ResectionYohei Tabe, Daisuke Asano, Hayato Takamizawa, et al.
Annals of Surgical Oncology|May 25, 2025
A Novel Transcriptomic Signature for Prediction of Response to Adjuvant Chemotherapy in Patients With Stages II and III Gastric CancerKenta Yao, Keisuke Okuno, Shuichi Watanabe, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Annals of Surgery|September 17, 2020
Curative Surgery and Ki-67 Value Rather Than Tumor Differentiation Predict the Survival of Patients With High-grade Neuroendocrine NeoplasmsDaisuke Asano, Atsushi Kudo, Keiichi Akahoshi, et al.
Anticancer Research|August 2, 2019
High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular CarcinomaShun-Ichi Ariizumi, Daisuke Ban, Yuta Abe, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2016
Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasmEriko Katsuta, Atsushi Kudo, Takumi Akashi, et al.
Journal of Gastroenterology|March 14, 2019
A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasmsBo Liu, Atsushi Kudo, Yuko Kinowaki, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2021
A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasmsTomotaka Kato, Atsushi Kudo, Yuko Kinowaki, et al.
Gastroenterology|April 19, 2012
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agentsRama Adikrisna, Shinji Tanaka, Shunsuke Muramatsu, et al.
Annals of Surgical Oncology|December 28, 2013
EpCAM-targeted therapy for human hepatocellular carcinomaKousuke Ogawa, Shinji Tanaka, Satoshi Matsumura, et al.
Cancer Science|September 12, 2021
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancersYoshiki Murase, Hiroaki Ono, Kosuke Ogawa, et al.
Surgical Case Reports|October 8, 2025
Late-Onset Para-Aortic Lymph Node Recurrence 11 Years after Resection of Pancreatic Cancer: Histological Reassessment Revealed Neuroendocrine Differentiation Amenable to Surgical ResectionYohei Tabe, Daisuke Asano, Hayato Takamizawa, et al.
Annals of Surgical Oncology|May 25, 2025
A Novel Transcriptomic Signature for Prediction of Response to Adjuvant Chemotherapy in Patients With Stages II and III Gastric CancerKenta Yao, Keisuke Okuno, Shuichi Watanabe, et al.
Pageof 18